Welcome to our dedicated page for Cadre Holdings SEC filings (Ticker: CDRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cadre Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cadre Holdings's regulatory disclosures and financial reporting.
Cadre Holdings insider files to sell additional shares under Rule 144. A holder plans to sell 24,000 shares of Cadre Holdings common stock through UBS Financial Services on the NYSE, with an aggregate market value of approximately $1,031,309.14. These shares were acquired as restricted stock units from the issuer on March 18, 2024.
As context, 40,663,844 shares of Cadre Holdings common stock were outstanding at the time of this notice. Over the past three months, the same seller completed multiple open-market sales, including a 27,370‑share transaction on November 13, 2025 that generated gross proceeds of $1,193,840. The seller represents that they are not aware of any undisclosed material adverse information about the company’s current or prospective operations.
Cadre Holdings (CDRE) received an updated Schedule 13D from major shareholder Warren B. Kanders, reflecting recent trades and his current stake. He now beneficially owns 11,692,570 shares of common stock, representing about 27.7% of the company. This total includes shares held directly, in his Roth IRA, through Kanders SAF, LLC, options to purchase 232,635 shares that are exercisable within 60 days, and 23,450 shares held in his wife’s Roth IRA. It excludes additional stock options and restricted stock units that are not yet exercisable or vested.
The ownership percentage is calculated using 42,245,528 shares deemed outstanding, including certain vested awards and in-the-money options. On November 17, 2025, Kanders sold 1,257,038 shares and Kanders SAF sold 86,903 shares of Cadre Holdings common stock in a Rule 144 block trade at $39.00 per share. Of the shares beneficially owned, a total of 3,750,000 shares have been pledged as collateral in favor of Texas Capital Bank under an existing loan agreement.
Cadre Holdings, Inc. (CDRE) CEO and Chairman Warren B. Kanders reported significant stock sales. On 11/17/2025, he sold 1,257,038 shares of Cadre common stock at $39 per share in a direct transaction, leaving him with 1,546 directly held shares. He also reported an indirect sale of 86,903 shares at $39 per share through Kanders SAF, LLC, after which that entity held 10,129,289 shares indirectly for him.
In addition, Kanders reported indirect beneficial ownership of 1,305,650 shares held in the Warren B. Kanders Roth IRA and 23,450 shares held in the Allison Kanders Roth IRA. He is listed as a director, 10% owner, and CEO and Chairman, and disclaims beneficial ownership of certain indirect holdings except to the extent of his pecuniary interest.
Cadre Holdings (CDRE) filed a Form 144 notice for the proposed sale of 1,343,941 common shares through broker Merrill Lynch on the NYSE, with an approximate sale date of 11/17/2025.
The shares listed have an aggregate market value of $56,566,477 based on the filing data. The filing reports that 40,663,844 shares of the issuer’s common stock are outstanding, providing context for the size of the potential sale.
The securities to be sold include shares acquired on 12/07/2021 via a liquidating distribution and shares acquired on 11/10/2025 upon the vesting and settlement of restricted stock units under the issuer’s 2021 Stock Incentive Plan.
Cadre Holdings, Inc. (CDRE) reported an insider stock sale by its President. According to the filing, the officer sold 27,370 shares of common stock on 11/13/2025 in an open-market transaction coded "S" (sale) at a weighted average price of $43.62 per share.
After this transaction, the reporting person beneficially owned 78,719 shares of Cadre Holdings common stock. The shares were sold in multiple trades within a price range of $43.50 to $43.82 per share, and detailed trade-by-trade information is available upon request as noted in the footnote.
A shareholder of Cadre Holdings (CDRE) has filed a Form 144 notice to sell 27,370 shares of common stock through a broker, with an indicated aggregate market value of 1,193,605. The shares are of a class that had 40,663,844 shares outstanding and the proposed sale is targeted around 11/13/2025 on the NYSE.
The securities to be sold were acquired from the issuer via several restricted stock unit (RSU) awards on 03/09/2024, 03/13/2024, 03/18/2024, and 03/13/2025, totaling multiple RSU grants. The filing also notes that Brad Williams has sold blocks of 4,132 shares of common stock on 09/23/2025, 10/14/2025, and 10/24/2025, for gross proceeds of 152,754, 165,150, and 177,546, respectively.
Cadre Holdings (CDRE): CEO and Chairman Warren B. Kanders reported the vesting and settlement of a previously granted restricted stock units award. On November 10, 2025, 2,000,000 restricted stock units vested and were converted into Common Stock. To cover tax obligations from this vesting, the issuer withheld 787,000 shares at $43.32 per share, leaving Kanders with 1,258,584 shares held directly.
Kanders also reports indirect holdings of 10,216,192 shares through Kanders SAF, LLC, 1,305,650 shares through the Warren B. Kanders Roth IRA, and 23,450 shares through the Allison Kanders Roth IRA. He is listed as Director, 10% Owner, and Officer (CEO and Chairman).
Cadre Holdings (CDRE) reported strong Q3 2025 growth. Net sales rose to $155.9 million from $109.4 million a year ago, lifting gross profit to $66.6 million from $40.0 million. Operating income increased to $18.7 million from $5.4 million, and net income improved to $10.9 million from $3.7 million, equal to diluted EPS of $0.27 versus $0.09. For the nine months, net sales reached $443.1 million (from $391.6 million) and diluted EPS was $0.79 (from $0.58).
The balance sheet expanded following M&A and credit facility draws. Total assets were $792.1 million (from $652.7 million) with cash and cash equivalents of $150.9 million. Long-term debt, net, was $295.0 million (from $211.8 million), reflecting the April draw of $97.5 million under the delayed draw term loan A‑1 to fund the Zircaloy acquisition, which had total consideration, net, of $89.6 million. Operating cash flow was $42.5 million (versus $8.1 million) year-to-date. The company declared quarterly dividends of $0.095 per share in each quarter of 2025 to date. Remaining performance obligations were $69.9 million as of September 30, 2025, with approximately 51% expected over the next twelve months.
Cadre Holdings (CDRE) filed an 8-K announcing it issued a press release with financial results for the quarter ended September 30, 2025. The release and an investor presentation were furnished as Exhibits 99.1 and 99.2.
The materials include non-GAAP measures such as EBITDA, adjusted EBITDA, adjusted EBITDA margin, and last twelve months adjusted EBITDA, with reconciliations to comparable GAAP metrics in the exhibits. The company noted it does not provide a reconciliation for full-year 2025 Adjusted EBITDA guidance due to forecasting limitations. The information under Item 2.02 is furnished, not filed. A conference call presentation is set for November 5, 2025.
Cadre Holdings announced a definitive agreement for subsidiary Safariland to acquire TYR Tactical and related entities for $145,000,000, composed of $130,000,000 in cash and $15,000,000 in Cadre common stock, including $14,000,000 in unregistered shares and $1,000,000 in restricted stock units for certain employees.
The Seller may receive up to $25,000,000 in earn-out payments tied to Net Revenue targets in 2026–2028, capped at $8,333,334 for the first year and $8,333,333 for each subsequent year, with payouts beginning at 50% of the cap at 90% of target and scaling linearly to 100% at target. Closing also requires a separate real estate acquisition in Peoria, Arizona for $30,000,000 ($20,000,000 cash and $10,000,000 in unregistered shares).
The deal is subject to HSR and other customary approvals and conditions. Closing is expected on the later of January 5, 2026 or the third business day after conditions are met. Cadre will file a Form S-3 within 60 days after closing to register the resale of the unregistered shares issued as consideration. If a party fails to close after conditions are satisfied, the breaching party owes $10,000,000 plus documented expenses, and Buyer may seek specific performance.